Menlo Park, California, United States
Helen Blau, Scott Delp
2017
Private company
Cell Loss
Duchenne muscular dystrophy
small molecule drugs
Myoforte Therapeutics a biopharmaceutical company that spun out of Stanford University, is dedicated to the development of novel strategies to build muscle strength. The company develops drugs that enhance the regenerative process by capitalizing on the body’s own healing mechanisms.